Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study.

Orlando L, Giotta F, Lorusso V, De Vita F, Filippelli G, Maiello E, Riccardi F, Pappagallo GL, Fedele P, Gebbia N, Verderame F, Barni S, Blasi L, Pisconti S, Colucci G, Cinieri S.

Future Oncol. 2014 Apr;10(5):725-33. doi: 10.2217/fon.13.186.

PMID:
24799054
[PubMed - in process]
2.

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.

Natoli C, Brocco D, Sperduti I, Nuzzo A, Tinari N, De Tursi M, Grassadonia A, Mazzilli L, Iacobelli S, Gamucci T, Vici P; “FOLLOW-UP” Study Group.

PLoS One. 2014 Apr 8;9(4):e94063. doi: 10.1371/journal.pone.0094063. eCollection 2014.

PMID:
24714591
[PubMed - in process]
Free PMC Article
3.

Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer.

Russo G, Cioffi G, Gori S, Tuccia F, Boccardi L, Khoury G, Lestuzzi C, Maurea N, Oliva S, Faggiano P, Tarantini L; ICARO (Italian CARdio-Oncological) Network.

J Cardiovasc Med (Hagerstown). 2014 Feb;15(2):141-6. doi: 10.2459/JCM.0b013e328365afb5.

PMID:
24534802
[PubMed - in process]
4.

Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.

Giotta F, Latorre A, Cramarossa A, Simone G, Florio C, Oliva S, Lorusso V.

Tumori. 2013 Nov-Dec;99(6):278e-81e. doi: 10.1700/1390.15468.

PMID:
24503803
[PubMed - indexed for MEDLINE]
5.

Gut peptide profile and chemotherapy-associated dyspepsia syndrome in patients with breast cancer undergoing FEC60 chemotherapy.

Riezzo G, Clemente C, Linsalata M, D'Attoma B, Orlando A, Campanella G, Giotta F, Russo F.

Anticancer Res. 2013 Nov;33(11):4951-7.

PMID:
24222135
[PubMed - indexed for MEDLINE]
6.

Nuclear NHERF1 expression as a prognostic marker in breast cancer.

Paradiso A, Scarpi E, Malfettone A, Addati T, Giotta F, Simone G, Amadori D, Mangia A.

Cell Death Dis. 2013 Nov 7;4:e904. doi: 10.1038/cddis.2013.439.

PMID:
24201803
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.

Divella R, Daniele A, Savino E, Palma F, Bellizzi A, Giotta F, Simone G, Lioce M, Quaranta M, Paradiso A, Mazzocca A.

Anticancer Res. 2013 Apr;33(4):1491-7.

PMID:
23564790
[PubMed - indexed for MEDLINE]
8.

The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.

Russo F, Linsalata M, Clemente C, D'Attoma B, Orlando A, Campanella G, Giotta F, Riezzo G.

BMC Cancer. 2013 Feb 4;13:56. doi: 10.1186/1471-2407-13-56.

PMID:
23379680
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer.

Danza K, Pilato B, Lacalamita R, Addati T, Giotta F, Bruno A, Paradiso A, Tommasi S.

Eur J Hum Genet. 2013 Aug;21(8):824-30. doi: 10.1038/ejhg.2012.273. Epub 2012 Dec 12.

PMID:
23232696
[PubMed - indexed for MEDLINE]
10.

Centromere 17 copy number alteration: negative prognostic factor in invasive breast cancer?

Petroni S, Addati T, Mattioli E, Caponio MA, Quero C, Rubini V, Giotta F, Simone G.

Arch Pathol Lab Med. 2012 Sep;136(9):993-1000. doi: 10.5858/arpa.2011-0327-OA.

PMID:
22938586
[PubMed - indexed for MEDLINE]
11.

Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis.

Tarantini L, Gori S, Faggiano P, Pulignano G, Simoncini E, Tuccia F, Ceccherini R, Bovelli D, Lestuzzi C, Cioffi G; ICARO (Italian CARdio-Oncologic) Network.

Ann Oncol. 2012 Dec;23(12):3058-63. doi: 10.1093/annonc/mds127. Epub 2012 Jun 13.

PMID:
22700991
[PubMed - indexed for MEDLINE]
Free Article
12.

Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer: marker of risk or cardioprotection in the real world?

Oliva S, Cioffi G, Frattini S, Simoncini EL, Faggiano P, Boccardi L, Pulignano G, Fioretti AM, Giotta F, Lestuzzi C, Maurea N, Sabatini S, Tarantini L; Italian Cardio-Oncological Network.

Oncologist. 2012;17(7):917-24. doi: 10.1634/theoncologist.2011-0445. Epub 2012 Jun 6.

PMID:
22673631
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study.

Clavarezza M, Mustacchi G, Casadei Gardini A, Del Mastro L, De Matteis A, Riccardi F, Adamo V, Aitini E, Amoroso D, Marchetti P, Gori S, Carrozza F, Maiello E, Giotta F, Dondi D, Venturini M.

BMC Cancer. 2012 Jun 6;12:216. doi: 10.1186/1471-2407-12-216.

PMID:
22672524
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Quality of life, fatigue and depression in Italian long-term breast cancer survivors.

Romito F, Cormio C, Giotta F, Colucci G, Mattioli V.

Support Care Cancer. 2012 Nov;20(11):2941-8. doi: 10.1007/s00520-012-1424-9. Epub 2012 Mar 8. No abstract available.

PMID:
22399132
[PubMed - indexed for MEDLINE]
15.

Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer.

Tarantini L, Cioffi G, Gori S, Tuccia F, Boccardi L, Bovelli D, Lestuzzi C, Maurea N, Oliva S, Russo G, Faggiano P; Italian Cardio-Oncologic Network.

J Card Fail. 2012 Feb;18(2):113-9. doi: 10.1016/j.cardfail.2011.10.015. Epub 2011 Dec 3.

PMID:
22300778
[PubMed - indexed for MEDLINE]
16.

A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study.

Vici P, Giotta F, Di Lauro L, Sergi D, Vizza E, Mariani L, Latorre A, Pizzuti L, D'Amico C, Giannarelli D, Colucci G.

Oncology. 2011;81(3-4):230-6. doi: 10.1159/000334432. Epub 2011 Nov 17.

PMID:
22094540
[PubMed - indexed for MEDLINE]
17.

Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with antidepressant.

Daniele A, Divella R, Paradiso A, Mattioli V, Romito F, Giotta F, Casamassima P, Quaranta M.

In Vivo. 2011 Nov-Dec;25(6):895-901. Review.

PMID:
22021682
[PubMed - indexed for MEDLINE]
18.

A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.

Vici P, Brandi M, Giotta F, Foggi P, Schittulli F, Di Lauro L, Gebbia N, Massidda B, Filippelli G, Giannarelli D, Di Benedetto A, Mottolese M, Colucci G, Lopez M.

Ann Oncol. 2012 May;23(5):1121-9. doi: 10.1093/annonc/mdr412. Epub 2011 Sep 28.

PMID:
21965475
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.

Vici P, Colucci G, Giotta F, Sergi D, Filippelli G, Perri P, Botti C, Vizza E, Carpino A, Pizzuti L, Latorre A, Giannarelli D, Lopez M, Di Lauro L.

J Exp Clin Cancer Res. 2011 Apr 12;30:39. doi: 10.1186/1756-9966-30-39.

PMID:
21481280
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

Vici P, Giotta F, DI Lauro L, Brandi M, Gebbia V, Foggi P, Lorusso V, Vitucci C, Sergi D, Fattoruso SI, Giannarelli D, Viola G, Corsetti S, Colucci G, Lopez M.

Anticancer Res. 2009 May;29(5):1841-5.

PMID:
19443414
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk